JOIN OMAR CANOSA, MD, MEDICAL DIRECTOR at ANXIETY INSTITUTE
Pharmacotherapy of Severe Anxiety Disorders
This presentation will focus on severe, complex and/or treatment-resistant anxiety disorders.
Anxiety disorders are a significant global health concern, trailing only depressive disorders in impact. While most cases are manageable with established therapies, achieving lasting remission is challenging. Severe anxiety cases, though less common, cause immense suffering and challenge standard treatment guidelines. This discussion will explore severe, complex, and treatment-resistant anxiety disorders. It will cover the landscape of anxiety disorders, emphasize severe cases’ challenges, explore established treatments, delve into difficult case scenarios, and suggest strategies for addressing severe anxiety disorders.